JANSSEN-CILAG FARMACEUTICA, LDA secures contract for Acquisition Of Ibrutinib Drug [420 Mg; Cap/Comp] For Ulscb

Portugal, Sept. 15 -- Portugal based JANSSEN-CILAG FARMACEUTICA, LDA has secured contract from Unidade Local De Saude De Castelo Branco, E.P.E. for Acquisition Of Ibrutinib Drug [420 Mg; Cap/Comp] For Ulscb. The value of the contract is worth 9519960 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....